Medical Care in China

Parkinson's disease
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Neurology and neurosurgery work togetherto develop a treatment plan based on the patient's condition.
Precise neurological diagnosiscombines imaging, electrophysiology, and laboratory tests.
Complex disease treatmentcovers cerebrovascular diseases, epilepsy, Parkinson's disease, and neuro-oncology.
Functional recovery supportcombined with rehabilitation therapy promotes the recovery of motor and cognitive functions.

Condition Guide

About Parkinson's disease

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Parkinson's disease is a chronic brain disorder caused by the degeneration of dopaminergic neurons in the substantia nigra of middle-aged and elderly individuals. Typical symptoms include hand tremors, limb rigidity, slowed movements, shuffling gait, and frequent falls. It may also be accompanied by constipation, decreased sense of smell, sleep disturbances, and depressed mood. Later stages may lead to cognitive decline. Treatment is based on oral dopaminergic medications, but long-term use can cause end-of-dose symptoms and dyskinesia. In the middle and late stages, neuromodulation surgery or non-invasive focused ultrasound may be added. Currently, medication and surgery can only improve symptoms and cannot cure the disease.


Cutting-edge high-precision diagnostic and treatment technologies

  1. Bilateral PVP with Magnetic Resonance Ultrasound : Magnetic resonance-guided focused ultrasound was approved by the Chinese NMPA in 2021 for the treatment of essential tremor or Parkinson's disease. In July 2025, the US FDA further approved it for the treatment of staged bilateral globus pallidus thalamus tract disease in the middle and late stages of Parkinson's disease. It is performed non-invasively, without craniotomy, and under local anesthesia.
  2. Dual-target DBS : The Xuanwu Hospital team published a study in 2026 on high-frequency STN plus ultra-low-frequency SNr dual-target deep brain stimulation, which can simultaneously improve motor symptoms and frozen gait; closed-loop adaptive DBS and implantable bidirectional brain-computer interface therapy have entered multi-center research.
  3. Third-generation COMT inhibitors : The global third-generation COMT inhibitor opiacapone capsules were launched in January 2025 through the Boao Lecheng Pilot Program. It is used for adult Parkinson's disease with end-of-dose motor fluctuations and can prolong levodopa exposure and reduce on-off fluctuations.
  4. Fifth Edition Guideline Update : The "Chinese Guidelines for the Treatment of Parkinson's Disease (Fifth Edition)" will be published in June 2026, adding new drugs and new dosage forms such as rotigotine sustained-release microsphere injection, salfedipine, and zonisamide, and managing them throughout the process according to evidence-based recommendations.

Care Overview

Parkinson's disease Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Gu Yuxiang

Chief Physician, Professor, Doctoral Supervisor, Director of Cerebrovascular Disease Subspecialty

Neurology

-Research areas : Cerebrovascular diseases, Moyamoya disease, intracranial aneurysms; - Areas of expertise: cerebrovascular complex surgery, intracranial and extracranial vascular bypass, FLOW00 intraoperative perfusion assessment; - Areas of expertise: Intracranial aneurysm, cerebral AVM, Moyamoya disease, spontaneous intracerebral hemorrhage; - Academic Highlights & Core Values: Innovative "Huashan Solution" for cerebrovascular composite surgery; Leading expert in surgical diagnosis and treatment of moy

Huashan Hospital Affiliated to Fudan University logo Affiliated Hospital Huashan Hospital Affiliated to Fudan University
Yuan Ying

Associate Chief Physician

Neurology

Research areas : neurogenic dysphagia, aphasia, cognitive rehabilitation; cutting-edge technology: stepwise rehabilitation for dysphagia after stroke; areas of expertise: dysphagia after brain injury, dysarthria, cognitive and memory decline; academic highlights: authoritative expert in speech and cognitive rehabilitation; core value: establishing screening and rehabilitation pathways for neurogenic swallowing and language disorders to reduce the risk of aspiration.

Xuanwu Hospital (First Clinical Medical College), Capital Medical University logo Affiliated Hospital Xuanwu Hospital (First Clinical Medical College), Capital Medical University
Wu Yi

Chief Physician, Professor, Doctoral Supervisor, Director of the Department of Rehabilitation Medicine , and Director of the Department of Rehabilitation Medicine, Shanghai Medical College of Fudan University.

Neurology

Research Areas : Rehabilitation assessment and treatment of functional impairments after stroke; rehabilitation treatment of hemiplegia due to stroke/traumatic brain injury, paraplegia due to spinal cord injury, altered consciousness, aphasia, and dysphagia. Cutting-Edge Technologies: Innovatively proposed the concept of "precise positioning, precise diagnosis, and precise rehabilitation," pioneering the integration of imaging, neurophysiology, and near-infrared brain function detection technologies into

Huashan Hospital Affiliated to Fudan University logo Affiliated Hospital Huashan Hospital Affiliated to Fudan University
Lu Jiahong

Chief Physician, Professor, Doctoral Supervisor, Director of the Neuroimmunology/Myopathy Subspecialty

Neurology

-Research areas : Myasthenia gravis, inflammatory myopathy, autoimmune encephalitis; - Areas of expertise: Neuromuscular antibody profiling, individualized immune modulation for myasthenia gravis, plasma exchange/immunoadsorption therapy; - Diseases specializing in: Myasthenia gravis, polymyositis, dermatomyositis, autoimmune encephalitis, neuromyelitis optica spectrum disorders; - Academic Highlights & Core Values: A leading authority on neuroimmunological diseases in China, the author of the national gu

Huashan Hospital Affiliated to Fudan University logo Affiliated Hospital Huashan Hospital Affiliated to Fudan University
Cheng Xin

Chief Physician, Professor, Doctoral Supervisor, Deputy Director of the Department of Neurology, Huashan Hospital.

Neurology

Research areas : Acute treatment of cerebrovascular diseases and clinical and basic research on cerebral small vessel diseases. Cutting-edge technology: Over 10 years of experience in managing the acute stroke green channel at Huashan Hospital; specializing in acute stroke treatment procedures, intravenous thrombolysis, endovascular therapy, and multimodal imaging assessment; leading a national key science and technology project and conducting original research on the pathogenesis of cerebral small vessel

Huashan Hospital Affiliated to Fudan University logo Affiliated Hospital Huashan Hospital Affiliated to Fudan University
Wang Yuping

Chief Physician, Professor, Doctoral Supervisor, Former Department Head

Neurology

Research areas : Epilepsy, sleep disorders, neuromodulation; Cutting-edge technologies: Magnetoencephalography (MEG) for epileptogenic focus localization, neuromodulation therapy for refractory epilepsy; Areas of expertise: All types of epilepsy, narcolepsy, restless legs syndrome; Academic highlights: Leading expert in epilepsy and sleep medicine in China; Core value: Establishing integrated diagnosis and treatment standards for epilepsy and sleep disorders in China. Su Fengzeng (Chief Physician, Profess

Xuanwu Hospital (First Clinical Medical College), Capital Medical University logo Affiliated Hospital Xuanwu Hospital (First Clinical Medical College), Capital Medical University

Patient Stories

See the Next Step Through Patient Journeys

Fighting NMDAR Encephalitis - Repelling a CASE 01
PATIENT JOURNEY

Fighting NMDAR Encephalitis - Repelling a "Rare" Invasion

Neurology

Patient records Name: Aisha Khan Age: 34 Nationality: Pakistan (Karachi) Diagnosis: Anti-NMDAR encephalitis (associated with ovarian teratoma) Treatment Hospital: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences – Neurology/Rheumatology/Obstetrics and Gynecology MDT Team In the video Aisha sent, she was holding her newborn baby, her face beaming with a happy and peaceful smile. In the video, she said, "Thank you for helping me fight off that 'rare' demon that almost took everyth

View case details →
Alzheimer's Disease - Unveiling the Mystery of CASE 02
PATIENT JOURNEY

Alzheimer's Disease - Unveiling the Mystery of "Forgetting"

RehabilitationNeurology

Patient records Name: David Miller Age: 68 Nationality: Australia (Melbourne) Diagnosis: Alzheimer's disease (stage of mild cognitive impairment progressing to dementia, Aβ-PET positive, ApoE ε4 carrier) Treatment Hospital: Department of Neurology, Xuanwu Hospital, Capital Medical University / National Clinical Research Center for Geriatric Diseases Mr. David's daughter sent me a video showing David sitting at the piano, playing Chopin's Nocturne with fluid grace. His eyes were focused, his fingers danc

View case details →
Primary Hemifacial Spasm - Releasing the CASE 03
PATIENT JOURNEY

Primary Hemifacial Spasm - Releasing the "Tight Band" on the Face

Neurology

Patient records Name: Tanaka Yuki Age: 55 Nationality: Japan (Fukuoka) Diagnosis: Primary hemifacial spasm (left side, 5-year course, reduced effectiveness of botulinum toxin treatment, severely affecting social life) Treatment Hospital: Department of Neurosurgery, West China Hospital of Sichuan University In the video sent by Ms. Yuki, she is dressed in an elegant kimono, smiling as she serves tea to guests in a tea ceremony classroom. Her expression is gentle and natural, with no more twitching in her l

View case details →
Drug-Refractory Temporal Lobe Epilepsy - Taming the Brain's CASE 04
PATIENT JOURNEY

Drug-Refractory Temporal Lobe Epilepsy - Taming the Brain's "Electrical Storm"

Neurology

Patient records Name: Lily Anderson Age: 28 Nationality: British (London) Diagnosis: Drug-resistant temporal lobe epilepsy (complex partial seizures, 4-5 seizures per month, MRI showing right hippocampal sclerosis) Treatment Hospital: Department of Neurosurgery, Huashan Hospital Affiliated to Fudan University Core technology: Precise anterior temporal lobectomy with brain functional area localization assistance under intraoperative awake anesthesia. In the latest video Lily sent, she stands confidently in

View case details →

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.